Choosing between tirzepatide and semaglutide depends on your individual health needs, weight loss goals, and how your body responds to each medication
However, questions remain about long-term safety, accessibility and cost, and the risks associated with pregnancy
As retatrutide has not yet received MHRA or EMA approval, there is no official UK prescribing information or regulatory safety guidance specific to this medicine at present
I looked around and realized I had only one full-length mirror, she says
Semaglutide and Tirzepatide also have warnings for the possibility of causing pancreatitis, gallbladder problems, hypoglycemia, acute kidney injury, diabetic retinopathy, increased heart rate, severe gastrointestinal disease, and suicidal behavior or thinking
Brand names and uses: Victoza: Type 2 diabetes (used off- label for weight loss) and to help prevent heart disease